Wenyu Wu

Wenyu Wu


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2019 in In Vitro Cellular & Developmental Biology - Animal
Verified
Journal Article
Closed access
PDF file
TYTao Ye
Tao Ye
NZNing Zhang
Ning Zhang
WWWenyu Wu
Wenyu Wu
BYBing Yang
Bing Yang
JWJinghui Wang
Jinghui Wang
DTDong-xin Tang
Dong-xin Tang

5 February 2024 in Aesthetic Plastic Surgery
Verified
Journal Article
Open access
PDF file
YXYun Xie
Yun Xie
HZHong yi Zhao
Hong yi Zhao
WWWenyu Wu
Wenyu Wu
JXJinhua Xu
Jinhua Xu
BLBi Li
Bi Li
QLQingfeng Li
Qingfeng Li
Background: Aesthetic improvement of the chin is increasingly requested by patients, including those of Chinese origin. Methods: A randomized, evaluator-blinded, no-treatment controlled study evaluated the effectiveness and safety of a flexible hyaluronic acid (HA) filler, Restylane® DefyneTM (HADEF), in the correction of chin retrusion in a Chinese adult population over 12 months after treatment. On Day 1, subjects were randomized 3:1 into two groups, HADEF or delayed-treatment controls, and those in the HADEF group were administered treatment. An optional touch-up treatment was administered 1 month after treatment to obtain optimal chin augmentation. The initially untreated control group was offered delayed-treatment after 6 months (including 1-month touch-up). Results: HADEF was superior to no-treatment in improving chin retrusion according to the blinded evaluator at 6 months [Galderma Chin Retrusion Scale (GCRS) responder rate (≥ 1-point improvement from baseline) of 81% vs. 5% for untreated controls; p < 0.001, meeting the primary effectiveness objective. A majority of subjects maintained improvement at 12 months (61% in the HADEF group). All subjects reported satisfaction with results at 6 months after treatment with HADEF and aesthetic improvement rates per the global aesthetic improvement scale (GAIS) were high for 12 months following treatment, with an acceptable safety profile. Conclusions: These results demonstrated HADEF to be effective and safe for the correction of mild-to-moderate chin retrusion in Chinese subjects, confirming findings previously observed in a western population. Level of Evidence I: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

1 November 2018 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
YBYunqi Bao
Yunqi Bao
KWKejia Wu
Kejia Wu
JLJinran Lin
Jinran Lin
YCYuchong Chen
Yuchong Chen
WWWenyu Wu
Wenyu Wu
Background: The incidence of hair loss among Chinese male has increased to 21.3 per hundred. Hair restoration has been an effective technique. Detailed hair distribution has a tremendous impact on the surgery design. Objective: To investigate the pattern of hair distribution in Chinese young adult males. Methods: A total of 1000 males without hair disease were enrolled. We evaluated the locations of the main anatomical marks at different sites on the scalp and analyzed the hair density and follicular unit structure using the standard photographs and trichoscope. Results: The hairline shapes were classified as: linear (48.7%), linear with central protrusion (27.9%), round (9.8%), round with central protrusion (13.7%). The average height of the median line was 6.78 ± 0.75 cm, the ratio of the median line and the forehead height was 0.333. The average distance from the parietal whorl to the vertical bimeatal line was 7.05 ± 3.32 cm, and most of the PWs were on the right (51.4%) and had a clockwise pattern (73.3%). The hair density was 171.12 ± 18.32 hairs/cm2 in the vertex. 1-hair follicular units were (75.90% and 56.39%) in anterior hairline and temporal area. Conclusion: Our study clearly assisted understanding of scalp anatomy and hair distribution in Chinese young adult males.

26 November 2019 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
PDF file
YWYan Wu
Yan Wu
YTYan Tian
Yan Tian
JXJinhua Xu
Jinhua Xu
SZShaomin Zhong
Shaomin Zhong
RWRuiyan Wang
Ruiyan Wang
WWWenyu Wu
Wenyu Wu
Background: Patients are increasingly aware of the aesthetic appearance of aging hands.Aims: To evaluate efficacy and safety of a hyaluronic acid gel for improving skin quality in aged skin of the dorsal hand.Methods: This was a 15‐month randomized, multi‐center, evaluator‐blinded, split‐hand, no treatment‐controlled study. Three treatments with hyaluronic acid gel were administered in the same hand in adult Chinese subjects with grade 2 or 3 (mild or moderate aging) on the Hand Grading Scale (HGS). The primary objective was to evaluate the difference at 3 months between treated and untreated hands, based on the blinded evaluator's HGS assessment. Secondary assessments included the Global Aesthetic Improvement Scale (GAIS), biophysical measurements (skin elasticity, skin roughness and hydration), and subject satisfaction. Safety was evaluated by incidence of adverse events.Results: A total of 100 subjects were enrolled. Clinically relevant differences in HGS favored HA gel (P < .0001). At 15 months, 87%‐96% of treated hands were still improved according to GAIS (per evaluator and subject, respectively). Objective measures of skin quality improved, confirmed by evaluators and highly satisfied subjects. Treatment was well tolerated.Conclusions: Hyaluronic acid treatment improved skin quality and reduced the aging appearance of the hand, with high subject satisfaction.

21 March 2023 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
PMPhilippe Massiot
Philippe Massiot
PPPedro Contreiras Pinto
Pedro Contreiras Pinto
SLStephanie Leclerc‐Mercier
Stephanie Leclerc‐Mercier
VRVirginie Rasmont
Virginie Rasmont
BPBianca Maria Piraccini
Bianca Maria Piraccini
DKDelphine Kerob
Delphine Kerob
Introduction: Scalp psoriasis frequently goes with other disease location and may lead to a significant burden and impairment of quality of life (QoL). Adherence to local treatments is a frequent problem. A keratolytic and hydrating shampoo containing 2% salicylic acid, 5% urea, and 1% glycerin (active shampoo) has been developed for psoriasis‐prone scalp.Objective: To assess the efficacy and tolerability of an active shampoo in subjects with mild to moderate scalp psoriasis.Materials and methods: A single‐center, randomized, double‐blind, vehicle‐controlled study was conducted on 67 adults with mild to moderate psoriasis. The active shampoo or its vehicle were applied daily for 14 days and 3 times/week for another 14 days. Assessments included the Psoriasis Scalp Severity Index (PSSI), Investigator Global Assessment (IGA), calculated total surface affected hair, scalp greasiness, irritation, and assessed scalp dermatitis–specific quality‐of‐life issues using SCALPDEX and product acceptability.Results: The active shampoo significantly (p < 0.05) reduced the PSSI by 39.0%, 37.2%, 63.0%, and 69.0% immediately after washing compared to a 22.8%, 5.5%, 19.6%, and 13.0% with the vehicle at Days 1, 8, 15, and 30, respectively. SCALPDEX items, IGA, and irritation significantly (p < 0.05) reduced with the active shampoo. Hair and scalp greasiness improved continuously with both products until Day 21. Subject‐reported symptom scores paralleled the positive evolution of clinical signs. The active shampoo was well tolerated, subjects were highly satisfied and had an improved QoL.Conclusion: The active shampoo significantly improved clinical signs, symptoms, and QoL of mild‐to‐moderate scalp psoriasis compared to the vehicle. It was very well tolerated and highly appreciated by the subjects.

1 June 2024 in Phenomics
Verified
Journal Article
Closed access
PDF file
ZSZhao Shuang
Zhao Shuang
ZLZhongling Luo
Zhongling Luo
YWYing Wang
Ying Wang
XGXinghua Gao
Xinghua Gao
JTJuan Tao
Juan Tao
XCXiang Chen
Xiang Chen